Addus HomeCare Corporation (ADUS) — Fair Value Analysis

Base-case fair value (P50): $110.32 · Current price: $103.55 · Verdict: Fairly Valued

The Verdict on ADUS

ADDUS HOMECARE CORP (ADUS) appears fairly valued at its current trading price of $103.55, according to our Monte Carlo simulations. Our median fair value (P50) for ADUS stands at $110.32, representing a modest +6.5% against the current market price. This indicates that while there's a slight upside based on our models, the stock is not significantly mispriced in either direction, aligning with our "Fairly Valued" verdict. Investors seeking substantial immediate arbitrage opportunities might find ADUS less compelling given this tight valuation gap between $103.55 and $110.32. The simulations suggest the market's current assessment of ADUS largely reflects its intrinsic value, making it a hold rather than a strong buy or sell at this moment.

How ADUS stacks up against Healthcare

Within the Healthcare sector, ADUS holds an "average" quality tier, indicating its operational and financial health are in line with industry peers. This average quality tier is factored into our Monte Carlo simulations, contributing to the fair value assessment of $110.32. The consistency in its quality suggests a stable, but not outstanding, performance profile compared to the broader sector. The fact that $103.55 is so close to $110.32, with only +6.5% implied upside, further reinforces the market's likely recognition of this average quality. Investors evaluating ADUS alongside other Healthcare opportunities should consider this qualitative assessment informing its quantitative fair value.

What this means for investors

For investors, ADUS's "Fairly Valued" status, with $103.55 sitting near our $110.32 estimate and a +6.5% differential, suggests a balanced outlook. While there isn't a strong signal for aggressive buying based purely on undervaluation, the stock's average quality tier provides a foundation of stability within the Healthcare sector. Long-term holders might appreciate the modest upside suggested by $110.32, whereas short-term traders might find the limited +6.5% less attractive. To understand the full range of possibilities, including bear and bull case scenarios, sign up for a free FairCurve account to see the full Monte Carlo distribution and track ADUS's fair value as new fundamentals are released.